B

Belluscura PLC
LSE:BELL

Watchlist Manager
Belluscura PLC
LSE:BELL
Watchlist
Price: 10.25 GBX 7.89% Market Closed
Market Cap: 17.3m GBX
Have any thoughts about
Belluscura PLC?
Write Note

Belluscura PLC
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Belluscura PLC
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
B
Belluscura PLC
LSE:BELL
Total Liabilities & Equity
$23.6m
CAGR 3-Years
65%
CAGR 5-Years
56%
CAGR 10-Years
N/A
Smith & Nephew PLC
LSE:SN
Total Liabilities & Equity
$10.5B
CAGR 3-Years
-1%
CAGR 5-Years
3%
CAGR 10-Years
N/A
LivaNova PLC
NASDAQ:LIVN
Total Liabilities & Equity
$2.5B
CAGR 3-Years
5%
CAGR 5-Years
0%
CAGR 10-Years
24%
EKF Diagnostics Holdings PLC
LSE:EKF
Total Liabilities & Equity
ÂŁ79.3m
CAGR 3-Years
-10%
CAGR 5-Years
-2%
CAGR 10-Years
-5%
Angle PLC
LSE:AGL
Total Liabilities & Equity
ÂŁ33m
CAGR 3-Years
-2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Creo Medical Group PLC
LSE:CREO
Total Liabilities & Equity
ÂŁ69.3m
CAGR 3-Years
-5%
CAGR 5-Years
9%
CAGR 10-Years
N/A
No Stocks Found

Belluscura PLC
Glance View

Market Cap
16.3m GBX
Industry
Health Care

Belluscura Plc engages in the provision of medical devices. The Company’s product, the X-PLO2R, is a lightweight portable oxygen concentrator (POC), which is designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The company focuses on devices and treatments involving oxygen. The X-PLO2R DX is designed to produce approximately six-liters pulse dose oxygen and approximately two-liters of flow oxygen. The firm is focused on developing the medical devices for treating people who are suffering from chronic lung diseases, such as the chronic obstructive pulmonary disease (COPD), respiratory distress caused by coronavirus disease (COVID-19), and other respiratory disorders.

BELL Intrinsic Value
11.52 GBX
Undervaluation 11%
Intrinsic Value
Price
B

See Also

What is Belluscura PLC's Total Liabilities & Equity?
Total Liabilities & Equity
23.6m USD

Based on the financial report for Dec 31, 2023, Belluscura PLC's Total Liabilities & Equity amounts to 23.6m USD.

What is Belluscura PLC's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
56%

Over the last year, the Total Liabilities & Equity growth was 0%. The average annual Total Liabilities & Equity growth rates for Belluscura PLC have been 65% over the past three years , 56% over the past five years .

Back to Top